PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsProveca
Proveca
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SialanarGlycopyrronium2016-09-15
—
AqumeldiEnalapril2023-11-152032-2036
Heart failure
,
Diabetic nephropathies
,
Left ventricular dysfunction
,
Rheumatoid arthritis
,
Edema
,
Malignant hypertension
,
Bartter syndrome
,
Hypertension
,
Nephrotic syndrome
,
Variant angina pectoris
,
Atrial fibrillation
,
Myocardial infarction
,
Atrial flutter
,
Supraventricular tachycardia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glycopyrronium
sialorrhea
,
neurodevelopmental disorders
Glycopyrronium bromide
healthy volunteers/patients
,
snoring
,
gastrointestinal diseases
,
depression
,
respiratory aspiration
,
renal insufficiency
,
intracranial hemorrhages
,
hemorrhage
,
stroke
,
brain ischemia
,
intracranial vasospasm
,
parkinson disease
,
urologic surgical procedures
,
skin diseases
,
sweat gland diseases
,
surgical amputation
,
covid-19
,
post-dural puncture headache
,
colonoscopy
,
hyperhidrosis
,
neurogenic bowel
,
constipation
,
fecal incontinence
,
burns
,
elective surgical procedures
,
replacement arthroplasty knee
,
replacement arthroplasty hip
,
hip fractures
,
blood coagulation
,
congenital abnormalities
,
cerebral palsy
,
intellectual disability
,
analgesia
,
agnosia
,
obstetrical anesthesia
,
obstetrical analgesia
,
inguinal hernia
,
hernia
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
lung diseases
,
asthma
,
neuromuscular blockade
,
spinal cord injuries
,
vomiting
,
sialorrhea
,
nausea
,
general anesthesia
,
postoperative nausea and vomiting
,
spinal anesthesia
,
anesthesia
,
anesthesia recovery period
,
urinary retention
,
hypotension
,
postoperative pain
,
critical illness
,
disease progression
,
dyspnea
,
type 2 diabetes mellitus
,
postoperative complications
,
intestinal diseases
,
ventral hernia
,
delayed emergence from anesthesia
,
neoplasms
,
urinary bladder neoplasms
,
paralysis
,
disease
,
headache
,
pain
,
nerve block
,
gallstones
,
cholelithiasis
,
cholecystolithiasis
,
delirium
,
emergence delirium
,
laparoscopic cholecystectomy
,
coronary artery disease
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
body weight
,
urologic neoplasms
,
laryngoscopy
,
laparoscopy
,
electromyography
,
respiratory-gated imaging techniques
,
obesity
,
gastric bypass
,
respiration
,
respiratory distress syndrome
,
newborn respiratory distress syndrome
,
epilepsy
,
seizures
,
neurofibromatoses
,
abdominal neoplasms
,
hydrocephalus
,
neurodevelopmental disorders
,
appendicitis
,
ileus
,
bradycardia
,
gallbladder diseases
,
acute cholecystitis
,
cholecystitis
,
rhytidoplasty
,
hysterectomy
,
diabetes mellitus
,
heart diseases
,
stomach neoplasms
,
abdominal hernia
,
internal hernia
,
bariatric surgery
,
acalculous cholecystitis
,
heart failure
,
peritoneal neoplasms
,
vitamin b 12 deficiency
,
macrocytic anemia
,
depressive disorder
,
premedication
,
fever
,
muscle hypotonia
,
intraoperative complications
,
thyroid diseases
,
intraoperative neurophysiological monitoring
,
chronic disease
,
neurologic manifestations
,
myasthenia gravis
,
muscle weakness
,
heart arrest
,
tachycardia
,
retrospective studies
,
head and neck neoplasms
,
sinusitis
,
otitis media
,
suppurative otitis media
,
paranasal sinus diseases
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use